Puma Biotechnology Presents Interim Results from the Biliary Tract Cancers Cohort of the Phase II SUMMIT "Basket" Trial of Neratinib at ASCO GI
LOS ANGELES--(BUSINESS WIRE)--Jan 15, 2021-- |!| Oelwein
LOS ANGELES--(BUSINESS WIRE)--Jan 15, 2021-- |!| Oelwein